Prologel

Cluneal neuralgia, typically caused by entrapment of the cluneal nerves, is a painful condition that is a common cause of lower back pain with an estimated incidence of 14%! (Kuniya et al., 2014).

Meet one of the newest additions to the ProloGel product line: ProloGel Acute Phase.

Powered by the same patented therapeutic method and base formulation with the addition of therapeutic agents intended to support rehabilitation of soft tissue injuries and pain associated with active living.

Available today!

New Reformulated and improved product line is live! Come and get yours!

Countdown to launch: 12:00:00

Countdown to launch: 15:34:00

Countdown to launch: 17:55:05

ProloGel’s Neurotherapy - a one-of-a-kind, patented therapeutic topical developed by rehabilitation specialists to support rehabilitation of conditions associated with persistent nerve symptoms.

It's here! ProloNura clear therapeutic serum for soothing relief of tension in head.

The next BIG thing: Launching Monday June 30!

ProloGel's new Face, Scalp and Neck Serum. So worth the wait!

Awareness of the role of superficial neurogenic inflammation in a musculoskeletal pain conditions has grown significantly over the past 5-10 years.

Patented ProloGel and the ProloGel diagnostic and therapeutic method remain the ideal therapeutic approach for this condition available to rehabilitation specialists today.

Chronic post-surgical pain (CPSP) usually has a neuropathic pain component. Entrapped or irritated superficial nerves can produce pain, swelling, itching, and increased sensitivity.

CPSP can pose a severe nuisance to patients, leading to functional limitation and psychological trauma, as well as a source of frustration and disappointment for a surgical team.

Estimates on prevalence range significantly from 5%-85%: As examples, 50%–85% following limb amputation, 11%–57% following mastectomy, 30%–55% following cardiac surgery, 5%–65% after thoracotomy, and 5%–63% following hernia repair.

Therapeutic topical application may help to moisturize surrounding tissue, assist with mobilization and combating adhesions, especially when coupled with a focused manual technique (e.g. circular self-massage).

Patented ProloGel Urgent Care serves a valuable, dual-purpose in the clinical armatorium of the pain and rehabilitation specialist:

As a practical diagnostic, it facilitates ruling out neurogenic inflammation as a component of the patient's pain complex.

As a therapeutic it is especially suited to acute presentations where nociceptive pain is significant and robust relief is required. A topical anesthetic is supplemented with ProloGel's patented base ingredients for a synergistic, pain relieving effect.

This window of relief can allow the rehabilitation specialist to introduce therapeutic movement and other modalities that might otherwise be limited by acute pain.

Each ProloGel product fills a specific use case in pain and physical rehabilitation.